aap Implantate AG
Develops, manufactures, and markets implants for the treatment of bone fractures.
AAQ1 | F
Overview
Corporate Details
- ISIN(s):
- DE000A32VP65 (+4 more)
- LEI:
- 39120001TRQTQ01LPP57
- Country:
- Germany
- Address:
- Lorenzweg 5, 12099 Berlin
- Website:
- https://www.aap.de/
- Sector:
- Manufacturing
Description
aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-25 15:03 | English | 5.1 KB | |||
| 2024-10-22 16:15 |
aap Implantate AG: Cash capital increase and intended non-cash capital increase
|
English | 7.4 KB | ||
| 2024-10-18 22:14 |
aap Implantate AG: Step-by-step restart of IT systems
|
English | 5.6 KB | ||
| 2024-10-15 23:25 |
aap Implantate AG: Possible cyber attack on aap
|
English | 4.9 KB | ||
| 2024-10-09 11:58 | German | 13.7 KB | |||
| 2024-10-09 11:53 | German | 13.1 KB | |||
| 2024-10-07 07:30 |
Progress in the MDR process - important MDR initial certification audit carried…
|
English | 8.7 KB | ||
| 2024-09-04 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 4.8 MB | ||
| 2024-09-03 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 3.4 MB | ||
| 2024-08-23 18:15 |
aap Implantate AG: annual financial statements 2023 characterized by the diffic…
|
English | 28.2 KB | ||
| 2024-08-22 18:05 |
aap Implantate AG: Auditor will terminate audit and declare non-issuance of aud…
|
English | 6.0 KB | ||
| 2024-08-14 19:15 |
Half-year financial statements close with balanced EBITDA, Trauma with positive…
|
English | 23.9 KB | ||
| 2024-08-14 00:00 |
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2024 bis zum 30.0…
|
German | 130.8 KB | ||
| 2024-08-08 15:05 |
aap Implantate AG: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlu…
|
German | 5.2 KB | ||
| 2024-07-29 09:48 | German | 13.7 KB |
Automate Your Workflow. Get a real-time feed of all aap Implantate AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for aap Implantate AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for aap Implantate AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-15 | di Girolamo, Rubino | Board | Buy | None | 990.00 EUR |
| 2023-03-30 | Deepblue Holding AG | Close relation | Other | None | 249,999.40 EUR |
| 2023-03-30 | Merval AG | Close relation | Other | None | 140,000.00 EUR |
| 2023-03-30 | di Girolamo, Rubino | Board | Other | None | 83,743.80 EUR |
| 2023-03-30 | Hahn, Marek | Board | Other | None | 52,920.00 EUR |
| 2023-03-30 | Mierzejewska, Agnieszka | Board | Other | None | 26,800.20 EUR |
| 2022-02-03 | Merval AG | Close relation | Other | None | 650,000.47 EUR |
| 2021-10-28 | Active Ownership Fund SICAV-FIS SCS | Close relation | Other | None | 60,792,157.00 EUR |
| 2021-10-27 | Merval AG | Close relation | Other | None | 318,324.60 EUR |
| 2021-10-27 | Visser, Biense | Supervisory board | Other | None | 3,573.90 EUR |
Peer Companies
